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The clinical course of five patients manifesting coronary
artery spasm at the site of previous successful percuta-
neous coronary angioplasty is reviewed. All patients
showed this spasm on hemodynamically insignificant
«50% diameter narrowing) obstruction. Four patients
did not respond to therapy with calcium channel antag-
onists and nitrates and subsequently developedrecurrent
Percutaneous transluminal coronary angioplasty is a new
method of myocardial revascularization. Through "con-
trolled injury" to the coronary artery wall, the angiographic
diameter of the artery is increased and the pressure gradient
across the lesion is reduced (1,2). Among the unsolved
problems associated with coronary angioplasty is restenosis,
which occurs in 25 to 30% of patients within 6 months after
angioplasty (2,3).
Myocardial ischemia associated with spasm of the epi-
cardial coronary arteries is now an accepted entity. Coronary
artery spasm sufficient to produce myocardial ischemia has
been shown to occur with all degrees of fixed obstruction
and may be present in vessels that appear normal on coro-
nary angiography (4-6). We review the experience with
five patients who developed coronary artery spasm at the
site of angioplasty during the first 2 months after angio-
plasty. Because these patients developed a recurrent ste-
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stenosis. One patient died 2 months after angioplasty
and 1 day after coronary bypass surgery. Pathologic
study at the site of angioplasty revealed new arthero-
sclerotic disease. Coronary spasm may occur during the
healing period after coronary angioplasty and should be
distinguished from fixed obstruction.
nosis, coronary artery spasm might precede the development
of recurrence. It is important to recognize that coronary
artery spasm may occur and to distinguish this spasm from
fixed obstruction.
Methods
Our method for performing coronary angioplasty has
been described previously (1,7). The only relevant change
in protocol from these earlier descriptions is that all patients
are now discharged on a regimen of aspirin, 325 mg daily
for 6 months. All lesions are measured in as many views
as possible, either manually or using an automated digital
caliper (A2D cinemetric viewer and Prodicall101 program-
mable digital caliper).
The protocol for the intravenous ergonovine provocative
test is a variation of a previously described method (8).
Initially, ergonovine, 0.05 mg, is given intravenously; after
2 minutes, another 0.1 mg is given and after 2 more minutes,
an additional 0.2 mg is given and coronary angiograms of
both coronary arteries are repeated. Ifchest pain occurs with
or without ST segment shift on the electrocardiogram or if
there is objective evidence of focal coronary artery spasm,
further doses of ergonovine are withheld. Nitroglycerin, lOa
J,Lg/cc dissolved in a 5% dextrose solution, is available for
prompt intracoronary infusion. For comparison, our first 52
consecutive patients presenting with exertional symptoms
and fixedobstructionson repeat catheterizationwere reviewed.
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Case Presentations
We observed five patients with coronary artery spasm
after undergoing coronary angioplasty. Their angiographic
data are summarized in Table 1. Two patients are selected
for presentation. Patient 3 was a typical patient with recur-
rence of anginal chest pain; Patient 5 died 2 weeks after
coronary angiography and demonstrated coronary spasm at
the site of angioplasty.
Patient 3. This patient was a 54 year old man with class
2 angina pectoris before angioplasty. Coronary angioplasty
resulted in a decrease in diameter narrowing of the left
anterior descending artery from 54 to 17% (Fig. lA and B).
After angioplasty, he was asymptomatic for 3 weeks when
he developed early morning and rest pain but no exertional
angina. Cardiac catheterization at 32 days demonstrated es-
sentially no change in the coronary luminal narrowing from
that in the immediate postangioplasty study; however, dur-
ing angiography a spontaneous episode of his typical rest
pain occurred and the area of previous angioplasty showed
progression to near total occlusion. This spasm resolved
with intracoronary and sublingual nitroglycerin (Fig. lC and
D). Despite vigorous attempts to control his symptoms with
large doses of long-acting nitrates and nifedipine (160 mg/day),
the rest symptoms continued.
At 5 months, his symptoms changed to exertional chest
pain. At this time, cardiac catheterization showed a 75%
recurrent obstruction in the proximal portion of the left
anterior descending artery that was unresponsive to intra-
coronary nitroglycerin and sublingual nifedipine (Fig. IE
and F). A repeat angioplasty was performed and the patient
was discharged on a regimen of large doses of a long-acting
nitrate and nifedipine (120 mg/day), which was continued
for 8 months. Administration of these medications was sub-
sequently tapered and discontinued. At the most recent re-
port, this patient was asymptomatic after more than 14 months
of follow-up. He has undergone maximal thallium exercise
testing while not receiving medication and has shown no
perfusion defect.
Patient 5. This 43 year old man had an anterior sub-
endocardial myocardial infarction 2 weeks before angio-
plasty. After routine pretreatment with nitrates and nifedi-
pine, the diseased left anterior descending coronary artery
appeared to be much less severely obstructed than it ap-
peared on the referral angiographic film done 1week earlier.
Coronary angioplasty resulted in a decrease in diameter
narrowing of the left anterior descending artery from 37 to
15%.
After coronary angioplasty, the patient was asympto-
matic for 50 days. At this time, he developed rest and
exertional angina that could not be controlled with nitrates
and nifedipine. During repeat angiography, the area of an-
gioplasty showed 90% obstruction (Fig. 2A). This was re-
duced to a 30% diameter narrowing after sublingual nitro-
glycerin (Fig. 2B). On the 64th day after angioplasty, the
patient underwent surgical saphenous vein bypass grafting
to the left anterior descending artery and its first diagonal
branch. On the morning after bypass surgery, the patient
died of an apparent myocardial infarction despite vigorous
attempts at resuscitation that included nitroglycerin injected
directly into the bypass grafts.
Examination of the heart at autopsy revealed moderate
coronary atherosclerosis with marked stenosis of the left
anterior descending coronary artery proximal to the points
of anastomosis with the still patent bypass grafts. Micro-
scopic examination of the stenosed coronary artery in the
segment that was dilated at angioplasty revealed a greatly
thickened intima consisting of two layers (Fig. 3). The outer
layer encroached on and thinned the media, and consisted
of old, hypocellular, fibrous atherosclerotic plaque contain-
Table 1. Coronary Features of Five Patients Demonstrating Coronary Spasm After Coronary Angioplasty
Case
2
3
4
5
% Diameter Narrowing of Coronary Lesion
Chest Pain Pre Post Post Post
Before PTCA PTCA PTCA Cath I Cath 2 Outcome
Rest and 43 22 30 39 No symptoms
exertional
Exertional 86 39 24 95 Repeat PTCA
performed
Exertional 57 17 25 75 Repeat PTCA
performed
Rest and 79 34 23 70 Repeat PTCA
exertional performed
Rest only; 37 15 30 Not performed Died at
nontransmural surgery
infarction
At repeat catheterization 2 (Cath 2), Patients 2, 3 and 4 had exertional symptoms and Patient I had no angina.
Post Cath I = repeat cardiac catheterization when the chest pain was nonexertional and occurred early in the morning; PTCA = percutaneous
transluminal coronary angioplasty.
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ing numerous cholesterol clefts. Central to this was a very
discrete cellular layer consisting of fibroblasts surrounded
by a faintly basophilic, loose interstitial material containing
collagen but lacking stainable elastin. This central layer was
0.3 to 0.7 mm thick. At the junction between the outer
hypocellular layer and the inner cellular layers, there were
a number of small capillaries and foci of recent hemorrhage.
Gross and microscopic examination of the anterior and
anteroseptal myocardium in the area supplied by the left
anterior descending artery distal to the site of angioplasty
showed multiple small foci of myocardial infarction. These
Figure 1. Patient 3. Coronary angiograms, A, Discrete 57% di-
ameter narrowing in the proximal left anterior descending cor-
onary artery (right anterior oblique projection). B, Reduced ste-
nosis (17%) after initial angioplasty. C, Follow-up angiogram at
32 days showing a nonsignificant lesion (25%) in the proximal left
anterior descending coronary artery. D, Angiogram during a spon-
taneous episode of chest pain. Note the severe proximal stenosis
and decreased flow in the left anterior descending coronary artery.
E, Follow-up angiogram at 5 months showing a significant lesion
(75%) not responsive to sublingual nitrates, intracoronary nitrates
and sublingual nifedipine. F, Result after repeat angioplasty. Note
the long intimal tear in the proximal left anterior descending coro-
nary artery.
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ranged in age from about 24 hours to several weeks (Fig.
4). No evidence of platelet fibrin thrombi was seen in as-
sociation with these microinfarcts. The intervening myo-
cardium showed only changes indicative of myocardial
hypertrophy.
Clinical features of patients with coronary spasm.
The clinical course of the five patients followed the same
pattern (Table 2): 1) There was chest pain at rest without
predictable exertional angina. 2) Coronary artery spasm was
demonstrated by cardiac catheterization. Three patients (Cases
1, 2 and 4) required ergonovine provocation to induce an-
giographic evidence of coronary spasm. 3) None of the
patients had evidence of hemodynamically significant fixed
obstruction. In Patients 3 and 5, the coronary spasm oc-
curred spontaneously during the catheterization. 4) In the
three patients (Cases 2, 3 and 4) who later presented with
fixed coronary stenosis, there was a gradual recurrence of
exertional angina. In one patient (Case 3) this was associated
with a loss of rest symptoms, but in the two other patients
(Cases 2 and 4) rest symptoms persisted until repeat coro-
nary angioplasty. Patient 1 showed recurrent coronary ob-
struction nearly as severe as the original lesion, but was
free of angina.
Time from angioplasty to repeat catheterization.
Because of the concern about recurrent stenosis, most pa-
tients with anginal type chest pain after coronary angioplasty
undergo recatheterization a few days to 2 weeks after the
onset of symptoms. The mean time from angioplasty to
repeat catheterization was 43 days for our patients who
manifested spasm. In 52 consecutive patients presenting
with fixed obstruction and recurrent angina, the mean time
from angioplasty to cardiac catheterization was 137 days
(Fig. 5). This difference in time to restudy was highly sig-
nificant (probability [p] < 0.001).
Discussion
Coronary spasm after angioplasty. This is the second
report of coronary artery spasm after successful angioplasty.
In contrast to the Montreal Heart Institute (9) which found
variant angina after angioplasty in 9 of 83 successfully treated
patients, our 5 patients represent 5 of the 6 angiographically
proven cases among approximately 1,000 successful at-
tempts. The higher incidence observed by the Montreal group
is probably due to their more aggressive search for variant
angina. We used only angiographic criteria in making the
diagnosis of coronary spasm, whereas the Montreal group
used both angiographic and electrocardiographic criteria.
More aggressive searching might have resulted in an inci-
dence similar to that reported by the Montreal group.
Recurrent obstruction after successful angioplasty.
Angiographic evidence of fixed obstruction has not been
Figure 2. Patient 5. Coronary angiograms. A, Repeat angiogram
showing severe 90% stenosis in the left anterior descending coro-
nary artery (left anterior oblique cranial projection). B, Same pro-
jection showing minimal residual stenosis after sublingual
nitroglycerin.
demonstrated prior to 1Yz months after angioplasty if the
patient had an adequate dilation. In the present investigation,
all of the patients with coronary artery spasm presented
within 2 months of angioplasty. Although there were fewer
symptoms of variant angina in patients receiving medical
therapy with nitrates and nifedipine, they were not com-
pletely eliminated in three patients; all three of these patients
presented with severe fixed obstruction and required repeat
dilation. Only one patient who became asymptomatic during
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on his angiogram 2 weeks before death. The greater severity
of disease observed on postmortem study compared with
that evident on premortem angiography has been previously
noted (10- 14). Because the new material in the intimal
plaque did not contain organized smooth muscle, the in-
creased tone of the artery must have been due to the smooth
muscle cells in the muscular media. Also, because coronary
spasm was apparent clinically and angiographically before
coronary angioplasty and not present clinically in the first
50 days after angioplasty, the angioplasty-induced balloon
injury may have damaged the muscular media sufficiently
so that temporarily the media was incapable of coronary
spasm. After healing, however, spasm was again possible.
Damage to the muscular media has been reported in the
coronary arteries of a patient who died within 2 days of
angioplasty (2) and in studies (15,16) of angioplasty in fresh
human cadaver coronary arteries.
The two-layeredatheroscleroticplaque seen in our patient
is different from that in the previously reported pathologic
studies (2) of early injury where only disruption of the media
and splitting of the atherosclerotic plaque were apparent. A
report (17) of three late autopsy cases shows that the lesions
look exactly the same as those of de novo atherosclerosis.
Death in our autopsy case, that of Patient 5 who died 64
days after angioplasty occurred later than death in the early
reported cases (:s 2 days) and earlier than the three deaths
in the late report (17) (80, 90 and 150 days, respectively,
after angioplasty). Thus, our case represents an important
intermediate stage.
Pathogenesis and prevention . In Patient 5, the intimal
damage produced at the time of coronary angioplasty ap-
parently stimulated rapid fibrous intimal proliferation that
partially restenosed the vessel. The punctate myocardial
infarction distal to the lesion is particularly disturbing. Al-
though no thrombi were seen at autopsy. one wonders if
the microinfarcts were due to distal microembolism of plate-
let fibrin thrombi formed when the left anterior descending
Cath = cardiac catheterization; LAD = left anteriordescending coro-
nary artery; PTCA = percutaneous transluminal coronary angioplasty;
RCA = right coronary artery . Catheterization times are the same as those
in Table I .
Table 2, Clinical Characteristics of Five Patients Demonstrating
Coronary Spasm After Coronary Angioplasty
Vessel PTCA to PTCA to Recurrence
Treated Spasm atCath Follow-Up of
Age (yr) With (days) Cath Fixed
Case & Sex PTCA (days) Stenosis
I 59 F LAD 49 217 No
2 43 M RCA 15 225 Yes
3 55 M LAD 32 153 Yes
4 56 F LAD 61 235 Yes
5 43 M LAD 59
Total 43 :t 17 204 :t 37
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medical therapy had no recurrence at restudy. All three
patients with recurrence of angina underwent repeat angio-
plasty and all were treated with nifedipine and nitrates even
though they had no symptoms. None have shown symptoms
of recurrent variant or exertional angina pectoris after their
second angioplasty. One patient had a repeat catheterization
that showed no recurrence 6 months after repeat coronary
angioplasty.
Postmortem correlation. Patient 5 died 2 weeks after
coronary arteriography which demonstrated coronary spasm.
At autopsy, a double layer atherosclerotic process was ev-
ident. The inner layer of intimal proliferation had occurred
rapidly. Much of the apparent narrowing was due to a re-
versible increase in coronary artery tone, which was evident
Figure 3. Patient 5. Histologic sections of the left anterior de-
scending coronary artery. A, Low power view showing a circum-
ferential atherosclerotic plaque consisting of an outer layer (0)
composed of mature fibrous tissuewith numerous cholesterol clefts
andaninner cellular layer(I)composed ofproliferatingmyointimal
cells separated by a basophilic intercellular matrix (hematoxylin-
eosin, magnification x 40). B, Higher power view showing inner
(I) and outer (0 ) layers of the plaque. Refractile elastic fibers
(arrow) are seen at the interphase between the two layers of the
plaque (hematoxylin-eosin, magnification x 100).
1044 HOLLMAN ET AL.
CORONARY SPASM AFTER ANGIOPLASTY
lACC Vol. 2, No. 6
December 1983:1039-45
Figure 4. Patient 5. Histologic sections of anterior left ventricle.
A, Small focus of acute myocardial infarction (arrow) about 24
hours old (hematoxylin-eosin, magnification x 100). B, Small
focus of recent myocardial infarction (arrow) about 3 weeks old
undergoing organization (hematoxylin-eosin, magnification X 40 ).
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Figure 5. Mean time from angioplasty to repeat cardiac cathe-
terization in 5 patients (Pts.) with coronary spasm and 52 patients
with fixed obstruction. M :':: SO = mean :':: standard deviation.
razone alone . The benefit of rout ine calcium antagonists ca n
be accurately tested only through a randomized trial.
Use of coronary angioplasty in variant angina. The
use of coronary angioplasty in variant angina, particularly
when assoc iated with angiographically insignificant disease ,
is still investigational. We have previously reported on two
patients success fully treated by coronary angioplasty (22) .
Those patient s and Patient 5 in this report all had symptoms
that were refractory to therapy with nitrates and calcium
antago nists . Despite the demonstrat ion of coronary spas m
in the repeat cardiac catheterization, a course of bypass
surgery was chosen for Patient 5. Many patients with variant
angina will do well with bypass surgery (23,24), but in
general the results are poorer than with other subsets of
patient s (25,26). Patient 5 died a primary cardiac death ,
presumably with coronary artery spasm, despite patent by-
pass grafts. This is in keeping with the observations of others
(27,28) that coronary spasm can persist despite patent grafts .
Conclusions. On the basis of these clinica l observations,
we bel ieve that the following conclusions might be drawn .
I) Coronary arte ry spasm may occur during the healing
phase after successful coronary artery angioplasty. 2) Th is
spasm, once establ ished , is difficult to control even with
calcium channel antagoni sts and nitrates. 3) Smooth muscle
in the undamaged or healin g media rather than new smooth
muscle growth in the new lesion are respon sible for the
foca l spas m. 4) If the spasm is not controlled, fixed ob-
struction at the site of angioplasty is likely. 5 ) Small foca l
areas of myocardial necrosis may develop in area s supplied
by the artery undergoing coronary spas m. The exact path-
ogene sis of these foci of necrosis is unkno wn , but it might
be a result of small platelet-fibrin emboli.
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coronary artery underwent reve rsible spasm . (The patient
experi enced rather frequent rest pain during the 2 week s
before bypass surgery.) Such a hypothesis is supported by
animal experiments ( 18) which have shown that focal ar-
terial constriction results in endothelial dama ge , which
produces exten sive platelet deposition and thrombus for-
mation . Embolization of these platelet fibrin thrombi may
result in small punctate myocardi al infarcts . Platelet adher-
ence to damaged endothelium and the release of mitogenetic
stimulating factor may be an important element in the de-
velopment of atherosclerosis (19,20). Thus, it is possible
that coronary spasm may play a role in the pathogenesis of
recurrent stenosis after coronary angioplasty .
It is logical to presume that the routine use of long -actin g
nitrates or slow ca lcium channel blocking drugs might de-
crease the probability of resteno sis after angioplasty. Pre-
limin ary data in a nonrandomized trial (2 1) showed that
patients treated with diltiazem and sulfapyrazone did not
benefit when compared with patients treated with sulfapy-
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